Abstract
(Abstracted from J Ultrasound Med 2020;39:471–480) Improvements in ultrasound technology, with better resolution and color mapping, have made it possible to assess the fetal heart both transvaginally and transabdominally as early as the first trimester. There is a growing interest in using this technology for the early detection of congenital heart defects (CHDs), which occurs in 5 to 9 per 1000 live births.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
